Sven Ante Lundberg - Insider Trading & Ownership

Entity
Individual
Location
C/O Crispr Therapeutics Ag, 200 Sidney Street, Cambridge, Massachusetts
Summary
The estimated net worth of Sven Ante Lundberg is at least $4.87 M dollars as of May 28, 2024. Sven Ante Lundberg is the President, CEO & PEO, Director of Merus N.V. and owns shares of Merus N.V. (MRUS) stock worth about $4.87 M. Sven Ante Lundberg is the Director of Homology Medicines, Inc. and owns shares of Q32 Bio Inc. (FIXX) stock worth about $685.
All Insider Reports
All Insider Reports

Ownership of Sven Ante Lundberg

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
MRUS Merus N.V. President, CEO & PEO, Director $4.87 M May 7, 2024
FIXX Q32 Bio Inc. Director $685 Mar 25, 2024
VOR Vor Biopharma Inc. Director May 23, 2024

Insider Transactions Reported by Sven Ante Lundberg:

Sym Company Class Transaction % Value $ Price $ Shares Shares After Date Ownership